Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Simrén M[au]:

Chronic constipation. Camilleri M et al. Nat Rev Dis Primers. (2017)

Update on Rome IV Criteria for Colorectal Disorders: Implications for Clinical Practice. Simren M et al. Curr Gastroenterol Rep. (2017)

Irritable bowel syndrome. Enck P et al. Nat Rev Dis Primers. (2016)

Search results

Items: 1 to 50 of 275

1.

Muscle performance and fatigue in compensated chronic liver disease.

Ekerfors U, Sunnerhagen KS, Westin J, Jakobsson Ung E, Marschall HU, Josefsson A, Simrén M.

Scand J Gastroenterol. 2019 Jul 9:1-9. doi: 10.1080/00365521.2019.1635638. [Epub ahead of print]

PMID:
31287334
2.

Fecal Incontinence Diagnosed by the Rome IV Criteria in the United States, Canada, and the United Kingdom.

Whitehead WE, Simren M, Busby-Whitehead J, Heymen S, van Tilburg MAL, Sperber AD, Palsson O.

Clin Gastroenterol Hepatol. 2019 May 30. pii: S1542-3565(19)30590-7. doi: 10.1016/j.cgh.2019.05.040. [Epub ahead of print]

PMID:
31154029
3.

Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries.

Tack J, Stanghellini V, Mearin F, Yiannakou Y, Layer P, Coffin B, Simren M, Mackinnon J, Wiseman G, Marciniak A; IBIS-C Study group.

BMC Gastroenterol. 2019 May 7;19(1):69. doi: 10.1186/s12876-019-0985-1.

4.

Anxiety and depression in irritable bowel syndrome: Exploring the interaction with other symptoms and pathophysiology using multivariate analyses.

Midenfjord I, Polster A, Sjövall H, Törnblom H, Simrén M.

Neurogastroenterol Motil. 2019 Aug;31(8):1-14. doi: 10.1111/nmo.13619. Epub 2019 May 5.

PMID:
31056802
5.

Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome.

Simrén M, Törnblom H, Palsson OS, Van Oudenhove L, Whitehead WE, Tack J.

Gastroenterology. 2019 Apr 22. pii: S0016-5085(19)36712-5. doi: 10.1053/j.gastro.2019.04.019. [Epub ahead of print]

PMID:
31022401
6.

Visceral sensitivity remains stable over time in patients with irritable bowel syndrome, but with individual fluctuations.

Josefsson A, Rosendahl A, Jerlstad P, Näslin G, Törnblom H, Simrén M.

Neurogastroenterol Motil. 2019 Jul;31(7):e13603. doi: 10.1111/nmo.13603. Epub 2019 Apr 22.

PMID:
31012215
7.

Fasting breath H2 and gut microbiota metabolic potential are associated with the response to a fermented milk product in irritable bowel syndrome.

Le Nevé B, Derrien M, Tap J, Brazeilles R, Cools Portier S, Guyonnet D, Ohman L, Störsrud S, Törnblom H, Simrén M.

PLoS One. 2019 Apr 4;14(4):e0214273. doi: 10.1371/journal.pone.0214273. eCollection 2019.

8.

Mucosal and systemic immune profiles differ during early and late phase of the disease in patients with active ulcerative colitis.

Mavroudis G, Magnusson MK, Isaksson S, Sundin J, Simrén M, Öhman L, Strid H.

J Crohns Colitis. 2019 Apr 4. pii: jjz072. doi: 10.1093/ecco-jcc/jjz072. [Epub ahead of print]

PMID:
30946450
9.

Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irritable bowel syndrome, based on tripartite network analysis.

Labus JS, Osadchiy V, Hsiao EY, Tap J, Derrien M, Gupta A, Tillisch K, Le Nevé B, Grinsvall C, Ljungberg M, Öhman L, Törnblom H, Simren M, Mayer EA.

Microbiome. 2019 Mar 21;7(1):45. doi: 10.1186/s40168-019-0656-z.

10.

Within- and Between-Subject Variation in Dietary Intake of Fermentable Oligo-, Di-, Monosaccharides, and Polyols Among Patients with Irritable Bowel Syndrome.

Nybacka S, Störsrud S, Liljebo T, Le Nevé B, Törnblom H, Simrén M, Winkvist A.

Curr Dev Nutr. 2018 Dec 24;3(2):nzy101. doi: 10.1093/cdn/nzy101. eCollection 2019 Feb.

11.

Symptoms compatible with functional bowel disorders are common in patients with quiescent ulcerative colitis and influence the quality of life but not the course of the disease.

Mavroudis G, Simren M, Jonefjäll B, Öhman L, Strid H.

Therap Adv Gastroenterol. 2019 Feb 19;12:1756284819827689. doi: 10.1177/1756284819827689. eCollection 2019.

12.

Person-centred inpatient care - A quasi-experimental study in an internal medicine context.

Jakobsson S, Eliasson B, Andersson E, Johannsson G, Ringström G, Simrén M, Jakobsson Ung E.

J Adv Nurs. 2019 Feb 21. doi: 10.1111/jan.13953. [Epub ahead of print]

PMID:
30793351
13.

Effects of the long-term storage of human fecal microbiota samples collected in RNAlater.

Tap J, Cools-Portier S, Pavan S, Druesne A, Öhman L, Törnblom H, Simren M, Derrien M.

Sci Rep. 2019 Jan 24;9(1):601. doi: 10.1038/s41598-018-36953-5.

14.

Oesophageal symptoms are common and associated with other functional gastrointestinal disorders (FGIDs) in an English-speaking Western population.

Josefsson A, Palsson O, Simrén M, Sperber AD, Törnblom H, Whitehead W.

United European Gastroenterol J. 2018 Dec;6(10):1461-1469. doi: 10.1177/2050640618798894. Epub 2018 Sep 6.

15.

Clinical and Cost Effectiveness of Online Cognitive Behavioral Therapy in Children With Functional Abdominal Pain Disorders.

Lalouni M, Ljótsson B, Bonnert M, Ssegonja R, Benninga M, Bjureberg J, Högström J, Sahlin H, Simrén M, Feldman I, Hedman-Lagerlöf E, Serlachius E, Olén O.

Clin Gastroenterol Hepatol. 2018 Nov 28. pii: S1542-3565(18)31320-X. doi: 10.1016/j.cgh.2018.11.043. [Epub ahead of print]

16.

Fecal chromogranins and secretogranins are linked to the fecal and mucosal intestinal bacterial composition of IBS patients and healthy subjects.

Sundin J, Stridsberg M, Tap J, Derrien M, Le Nevé B, Doré J, Törnblom H, Simrén M, Öhman L.

Sci Rep. 2018 Nov 14;8(1):16821. doi: 10.1038/s41598-018-35241-6.

17.

Development of a real-time patient-reported outcome measure for symptom assessment in patients with functional dyspepsia using the experience sampling method.

Smeets FGM, Keszthelyi D, Vork L, Tack J, Talley NJ, Simren M, Aziz Q, Ford AC, Conchillo JM, Kruimel JW, Van Os J, Masclee AAM.

Neurogastroenterol Motil. 2019 Feb;31(2):e13496. doi: 10.1111/nmo.13496. Epub 2018 Nov 4.

PMID:
30393939
18.

Subgroups of IBS patients are characterized by specific, reproducible profiles of GI and non-GI symptoms and report differences in healthcare utilization: A population-based study.

Polster AV, Palsson OS, Törnblom H, Öhman L, Sperber AD, Whitehead WE, Simrén M.

Neurogastroenterol Motil. 2019 Jan;31(1):e13483. doi: 10.1111/nmo.13483. Epub 2018 Nov 4.

PMID:
30393924
19.

Reply.

Clevers E, Whitehead WE, Palsson OS, Sperber AD, Törnblom H, Van Oudenhove L, Tack J, Simrén M.

Clin Gastroenterol Hepatol. 2019 Apr;17(5):1002-1004. doi: 10.1016/j.cgh.2018.10.009. Epub 2018 Oct 10. No abstract available.

PMID:
30315945
20.

Evidence of increased fecal granins in children with irritable bowel syndrome and correlates with symptoms.

Shulman RJ, Öhman L, Stridsberg M, Cain K, Simrén M, Heitkemper M.

Neurogastroenterol Motil. 2019 Jan;31(1):e13486. doi: 10.1111/nmo.13486. Epub 2018 Oct 9.

PMID:
30298961
21.

Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem.

Frändemark Å, Törnblom H, Jakobsson S, Simrén M.

Am J Gastroenterol. 2018 Oct;113(10):1540-1549. doi: 10.1038/s41395-018-0262-x. Epub 2018 Sep 25.

PMID:
30254230
22.

Altered intestinal antibacterial gene expression response profile in irritable bowel syndrome is linked to bacterial composition and immune activation.

Bennet SMP, Sundin J, Magnusson MK, Strid H, Tap J, Derrien M, Le Nevé B, Doré J, Törnblom H, Simrén M, Öhman L.

Neurogastroenterol Motil. 2018 Dec;30(12):e13468. doi: 10.1111/nmo.13468. Epub 2018 Sep 17.

PMID:
30230134
23.

Manipulating the Gut Microbiome as a Treatment Strategy for Functional Gastrointestinal Disorders.

Simrén M.

Gastroenterology. 2018 Oct;155(4):960-962. doi: 10.1053/j.gastro.2018.09.008. Epub 2018 Sep 8. No abstract available.

PMID:
30201361
24.

Funding for gastrointestinal disease research in the European Union.

Törnblom H, Simrén M, Barbara G, Niesler B.

Lancet Gastroenterol Hepatol. 2018 Sep;3(9):593-595. doi: 10.1016/S2468-1253(18)30203-6. Epub 2018 Aug 8. No abstract available. Erratum in: Lancet Gastroenterol Hepatol. 2018 Oct;3(10):e5.

PMID:
30102177
25.

Pre- and perinatal stress and irritable bowel syndrome in young adults - A nationwide register-based cohort study.

Olén O, Stephansson O, Backman AS, Törnblom H, Simrén M, Altman M.

Neurogastroenterol Motil. 2018 Nov;30(11):e13436. doi: 10.1111/nmo.13436. Epub 2018 Aug 7.

PMID:
30084125
26.

New treatments and therapeutic targets for IBS and other functional bowel disorders.

Simrén M, Tack J.

Nat Rev Gastroenterol Hepatol. 2018 Oct;15(10):589-605. doi: 10.1038/s41575-018-0034-5. Review.

PMID:
29930260
27.

How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors.

Aziz I, Törnblom H, Palsson OS, Whitehead WE, Simrén M.

Am J Gastroenterol. 2018 Jul;113(7):1017-1025. doi: 10.1038/s41395-018-0074-z. Epub 2018 Jun 8.

PMID:
29880963
28.

Epidemiology, Clinical Characteristics, and Associations for Rome IV Functional Nausea and Vomiting Disorders in Adults.

Aziz I, Palsson OS, Whitehead WE, Sperber AD, Simrén M, Törnblom H.

Clin Gastroenterol Hepatol. 2019 Apr;17(5):878-886. doi: 10.1016/j.cgh.2018.05.020. Epub 2018 May 29.

PMID:
29857155
29.

Neither self-reported atopy nor IgE-mediated allergy are linked to gastrointestinal symptoms in patients with irritable bowel syndrome.

Nybacka S, Öhman L, Störsrud S, Mybeck M, Böhn L, Wilpart K, Winkvist A, Bengtsson U, Törnblom H, Simrén M.

Neurogastroenterol Motil. 2018 Oct;30(10):e13379. doi: 10.1111/nmo.13379. Epub 2018 Jun 1.

PMID:
29856100
30.

Systemic cytokines are elevated in a subset of patients with irritable bowel syndrome but largely unrelated to symptom characteristics.

Bennet SMP, Palsson O, Whitehead WE, Barrow DA, Törnblom H, Öhman L, Simrén M, van Tilburg MAL.

Neurogastroenterol Motil. 2018 Oct;30(10):e13378. doi: 10.1111/nmo.13378. Epub 2018 May 24.

PMID:
29797382
31.

Functional Dyspepsia and Severity of Psychologic Symptoms Associate With Postprandial Symptoms in Patients With Irritable Bowel Syndrome.

Pohl D, Van Oudenhove L, Törnblom H, Le Nevé B, Tack J, Simrén M.

Clin Gastroenterol Hepatol. 2018 Nov;16(11):1745-1753.e1. doi: 10.1016/j.cgh.2018.04.034. Epub 2018 Apr 24.

PMID:
29702295
32.

Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome.

Bonfiglio F, Zheng T, Garcia-Etxebarria K, Hadizadeh F, Bujanda L, Bresso F, Agreus L, Andreasson A, Dlugosz A, Lindberg G, Schmidt PT, Karling P, Ohlsson B, Simren M, Walter S, Nardone G, Cuomo R, Usai-Satta P, Galeazzi F, Neri M, Portincasa P, Bellini M, Barbara G, Latiano A, Hübenthal M, Thijs V, Netea MG, Jonkers D, Chang L, Mayer EA, Wouters MM, Boeckxstaens G, Camilleri M, Franke A, Zhernakova A, D'Amato M.

Gastroenterology. 2018 Jul;155(1):168-179. doi: 10.1053/j.gastro.2018.03.064. Epub 2018 Apr 5.

33.

Expert consensus document: Advances in the diagnosis and classification of gastric and intestinal motility disorders.

Keller J, Bassotti G, Clarke J, Dinning P, Fox M, Grover M, Hellström PM, Ke M, Layer P, Malagelada C, Parkman HP, Scott SM, Tack J, Simren M, Törnblom H, Camilleri M; International Working Group for Disorders of Gastrointestinal Motility and Function.

Nat Rev Gastroenterol Hepatol. 2018 May;15(5):291-308. doi: 10.1038/nrgastro.2018.7. Epub 2018 Apr 6. Review.

PMID:
29622808
34.

Heart rate variability characteristics of patients with irritable bowel syndrome and associations with symptoms.

Polster A, Friberg P, Gunterberg V, Öhman L, Le Nevé B, Törnblom H, Cvijovic M, Simren M.

Neurogastroenterol Motil. 2018 Jul;30(7):e13320. doi: 10.1111/nmo.13320. Epub 2018 Mar 25.

PMID:
29575352
35.

Health problems associated with irritable bowel syndrome: analysis of a primary care registry.

Clevers E, Vaes B, Henrard S, Goderis G, Tack J, Törnblom H, Simrén M, Van Oudenhove L.

Aliment Pharmacol Ther. 2018 May;47(10):1349-1357. doi: 10.1111/apt.14612. Epub 2018 Mar 24.

PMID:
29572885
36.

ABC om - IBS – irritabel tarm.

Lagerlöf E, Agreus L, Simrén M, Törnblom H.

Lakartidningen. 2018 Mar 7;115. pii: EXDU. Swedish. No abstract available.

37.

Relationships between psychological state, abuse, somatization and visceral pain sensitivity in irritable bowel syndrome.

Grinsvall C, Törnblom H, Tack J, Van Oudenhove L, Simrén M.

United European Gastroenterol J. 2018 Mar;6(2):300-309. doi: 10.1177/2050640617715851. Epub 2017 Jun 20.

38.

Factor Analysis Defines Distinct Upper and Lower Gastrointestinal Symptom Groups Compatible With Rome IV Criteria in a Population-based Study.

Clevers E, Whitehead WE, Palsson OS, Sperber AD, Törnblom H, Van Oudenhove L, Tack J, Simrén M.

Clin Gastroenterol Hepatol. 2018 Aug;16(8):1252-1259.e5. doi: 10.1016/j.cgh.2018.02.042. Epub 2018 Mar 3.

PMID:
29510215
39.

Development of Irritable Bowel Syndrome Features Over a 5-year Period.

Clevers E, Tack J, Törnblom H, Ringström G, Luyckx K, Simrén M, Van Oudenhove L.

Clin Gastroenterol Hepatol. 2018 Aug;16(8):1244-1251.e1. doi: 10.1016/j.cgh.2018.02.043. Epub 2018 Mar 3.

PMID:
29510214
40.

Psychological distress, iron deficiency, active disease and female gender are independent risk factors for fatigue in patients with ulcerative colitis.

Jonefjäll B, Simrén M, Lasson A, Öhman L, Strid H.

United European Gastroenterol J. 2018 Feb;6(1):148-158. doi: 10.1177/2050640617703868. Epub 2017 Apr 3.

41.

Increased Prevalence of Rare Sucrase-isomaltase Pathogenic Variants in Irritable Bowel Syndrome Patients.

Garcia-Etxebarria K, Zheng T, Bonfiglio F, Bujanda L, Dlugosz A, Lindberg G, Schmidt PT, Karling P, Ohlsson B, Simren M, Walter S, Nardone G, Cuomo R, Usai-Satta P, Galeazzi F, Neri M, Portincasa P, Bellini M, Barbara G, Jonkers D, Eswaran S, Chey WD, Kashyap P, Chang L, Mayer EA, Wouters MM, Boeckxstaens G, Camilleri M, Franke A, D'Amato M.

Clin Gastroenterol Hepatol. 2018 Oct;16(10):1673-1676. doi: 10.1016/j.cgh.2018.01.047. Epub 2018 Feb 21.

42.

Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study.

Aziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE, Simrén M.

Lancet Gastroenterol Hepatol. 2018 Apr;3(4):252-262. doi: 10.1016/S2468-1253(18)30003-7. Epub 2018 Feb 1.

PMID:
29396034
43.

Chronic constipation.

Camilleri M, Ford AC, Mawe GM, Dinning PG, Rao SS, Chey WD, Simrén M, Lembo A, Young-Fadok TM, Chang L.

Nat Rev Dis Primers. 2017 Dec 14;3:17095. doi: 10.1038/nrdp.2017.95. Review.

PMID:
29239347
44.

The endoscopic surveillance of the transplanted small intestine: a single center experience and a proposal for a grading score.

Varkey J, Stotzer PO, Simrén M, Herlenius G, Oltean M.

Scand J Gastroenterol. 2018 Feb;53(2):134-139. doi: 10.1080/00365521.2017.1411523. Epub 2017 Dec 12.

PMID:
29233031
45.

Validation of Fatigue Impact Scale with various item sets - a Rasch analysis.

Lundgren-Nilsson Å, Tennant A, Jakobsson S, Simrén M, Taft C, Dencker A.

Disabil Rehabil. 2019 Apr;41(7):840-846. doi: 10.1080/09638288.2017.1411983. Epub 2017 Dec 12.

PMID:
29228839
46.

Breath Testing Consensus Guidelines for SIBO: RES IPSA LOCQUITOR.

Paterson W, Camilleri M, Simren M, Boeckxstaens G, Vanner SJ.

Am J Gastroenterol. 2017 Dec;112(12):1888-1889. doi: 10.1038/ajg.2017.233. No abstract available.

PMID:
29215610
47.

The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries.

Aziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE, Simrén M.

Am J Gastroenterol. 2018 Jan;113(1):86-96. doi: 10.1038/ajg.2017.421. Epub 2017 Nov 14.

PMID:
29134969
48.

Development, content validity, and cross-cultural adaptation of a patient-reported outcome measure for real-time symptom assessment in irritable bowel syndrome.

Vork L, Keszthelyi D, Mujagic Z, Kruimel JW, Leue C, Pontén I, Törnblom H, Simrén M, Albu-Soda A, Aziz Q, Corsetti M, Holvoet L, Tack J, Rao SS, van Os J, Quetglas EG, Drossman DA, Masclee AAM.

Neurogastroenterol Motil. 2018 Mar;30(3). doi: 10.1111/nmo.13244. Epub 2017 Nov 6.

PMID:
29106029
49.

miR-16 and miR-103 impact 5-HT4 receptor signalling and correlate with symptom profile in irritable bowel syndrome.

Wohlfarth C, Schmitteckert S, Härtle JD, Houghton LA, Dweep H, Fortea M, Assadi G, Braun A, Mederer T, Pöhner S, Becker PP, Fischer C, Granzow M, Mönnikes H, Mayer EA, Sayuk G, Boeckxstaens G, Wouters MM, Simrén M, Lindberg G, Ohlsson B, Schmidt PT, Dlugosz A, Agreus L, Andreasson A, D'Amato M, Burwinkel B, Bermejo JL, Röth R, Lasitschka F, Vicario M, Metzger M, Santos J, Rappold GA, Martinez C, Niesler B.

Sci Rep. 2017 Oct 31;7(1):14680. doi: 10.1038/s41598-017-13982-0.

50.

Editorial: subgroups in irritable bowel syndrome-more than just diarrhoea and constipation? Authors' reply.

Polster A, Van Oudenhove L, Jones M, Öhman L, Törnblom H, Simrén M.

Aliment Pharmacol Ther. 2017 Oct;46(7):698-699. doi: 10.1111/apt.14260. No abstract available.

Supplemental Content

Loading ...
Support Center